Biologic Drugs

Sep 28, 2018
While food, shelter, and clothing are the primal essentials for life, hope—as embodied by modern medicine—has now become part of that human expectation.
Sep 28, 2018
By Pharmaceutical Technology Editors
CPhI releases the bio trends portion of its annual report, which predicts an increase in bioconjucation expertise and biopharma productivity over the next five years.
Sep 25, 2018
By Pharmaceutical Technology Editors
Cell-line quality has a significant impact on biologic drug quality; learn more about this and other upstream challenges at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.
Sep 21, 2018
By Pharmaceutical Technology Editors
The European Medicines Agency has recommended Luxturna (voretigene neparvovec) as the first treatment option for hereditary retinal dystrophy with mutations of the RPE65 gene.
Sep 20, 2018
By Pharmaceutical Technology Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Sep 13, 2018
By Pharmaceutical Technology Editors
The collaboration will focus on developing manufacturing solutions for biosimilars.
Sep 10, 2018
By Pharmaceutical Technology Editors
The collaboration will explore the potential of Dyadic’s gene-expression platform to produce multiple biologic vaccines and drugs.
Sep 07, 2018
By Pharmaceutical Technology Editors
New products were developed as next-generation process intensification technologies, MilliporeSigma reports.
Sep 02, 2018
Pharmaceutical Technology
Single-use technologies, modular systems, and robots are on the rise.
Sep 01, 2018
Pharmaceutical Technology
Immobilizing the antibodies on a solid-phase support, such as a resin, and carrying out the conjugation of the payload-linker while the antibodies are bound to that support will prevent aggregation at its source.
native1_300x100
lorem ipsum